Epidemiological considerations for development of a schistosome vaccine.
D000818:Animals; D003429:Cross Reactions; D005260:Female; D006801:Humans; D008297:Male; D012547:Schistosoma / Q000276:immunology*; D012548:Schistosoma haematobium / Q000276:immunology; D012550:Schistosoma mansoni / Q000276:immunology; D012552:Schistosomiasis / Q000453:epidemiology* / Q000517:prevention & control; D012553:Schistosomiasis haematobia / Q000453:epidemiology / Q000517:prevention & control; D012555:Schistosomiasis mansoni / Q000453:epidemiology / Q000517:prevention & control; D014612:Vaccines; D015047:Zoonoses
D014612:Vaccines